Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Plans IRS Settlement

Executive Summary

Boston Sci plans to pay $275m to settle transfer-pricing disputes with the US Internal Revenue Service. A financial analyst views the settlement as a win for the company because it’s well below what the IRS initially sought.

You may also be interested in...



Boston Scientific Settles $610M Tax Dispute

The giant device-maker has settled a long-running dispute over transfer pricing with the US Internal Revenue Service. Boston Scientific expects to pay almost $610m in back taxes and interest.

Tax Court Backs Medtronic In Transfer-Payment Dispute

The ruling means a larger portion of the company’s earnings can be taxed at the lower rate applied to foreign corporations.

Class I Recall On Abbott Coronary Catheters

The US FDA has announced a high-risk class I recall on two makes of coronary dilation catheters made by Abbott Vascular because a manufacturing issue could lead to difficulties deflating the balloon. The catheters have been linked to 13 complaints and one death.

Topics

Related Companies

UsernamePublicRestriction

Register

MT103622

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel